![Minako Pazdera](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Minako Pazdera
Conseiller Juridique Général chez Carmot Therapeutics, Inc.
Postes actifs de Minako Pazdera
Sociétés | Poste | Début | Fin |
---|---|---|---|
Carmot Therapeutics, Inc.
![]() Carmot Therapeutics, Inc. BiotechnologyHealth Technology Carmot Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of therapeutics for metabolic diseases, cancer, and inflammation. Its pipeline includes CT-388, CT-996, and CT-868. The CT-388 refers to treatment taken once-weekly subcutaneous injectable for obesity and type 2 diabetes (T2D). The CT-996 comprises of once-daily oral treatment for obesity and T2D. The CT-868 consists of once-daily subcutaneous injectable for treatment of type 1 diabetes (T1D) patients with overweight or obesity. The company was founded in 2008 and is headquartered in Berkeley, CA. | Conseiller Juridique Général | 01/01/2023 | - |
Secrétaire Général | 01/01/2023 | - |
Historique de carrière de Minako Pazdera
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
General Counsel | 1 |
Corporate Secretary | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Carmot Therapeutics, Inc.
![]() Carmot Therapeutics, Inc. BiotechnologyHealth Technology Carmot Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of therapeutics for metabolic diseases, cancer, and inflammation. Its pipeline includes CT-388, CT-996, and CT-868. The CT-388 refers to treatment taken once-weekly subcutaneous injectable for obesity and type 2 diabetes (T2D). The CT-996 comprises of once-daily oral treatment for obesity and T2D. The CT-868 consists of once-daily subcutaneous injectable for treatment of type 1 diabetes (T1D) patients with overweight or obesity. The company was founded in 2008 and is headquartered in Berkeley, CA. | Health Technology |
- Bourse
- Insiders
- Minako Pazdera
- Expérience